Long-term safety of nebulized lidocaine for adults with difficult-to-control chronic cough: A case series

Chest

Volumn 143, Issue 4, 2013, Pages 1060-1065

  Lim, Kaiser G ^a   Rank, Matthew A ^a   Hahn, Peter Y ^a,b   Keogh, Karina A ^a   Morgenthaler, Timothy I ^a   Olson, Eric J ^a  

^a MAYO CLINIC   (United States)

^b Tuality Health Care   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIDOCAINE;

ADULT; AGED; AGITATION; AIRWAY OBSTRUCTION; ARTICLE; CHRONIC DISEASE; CONTROLLED STUDY; COUGHING; DISEASE CONTROL; DISEASE DURATION; DISEASE SEVERITY; DISORIENTATION; DROWSINESS; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG SAFETY; DRUG SELF ADMINISTRATION; DRUG WITHDRAWAL; DYSPNEA; FEMALE; HEART PALPITATION; HEART RHYTHM; HUMAN; MAJOR CLINICAL STUDY; MALE; MOUTH IRRITATION; MUSCLE TWITCH; NEBULIZATION; PATIENT ATTITUDE; PATIENT EDUCATION; PATIENT SATISFACTION; PNEUMONIA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCORING SYSTEM; SIDE EFFECT; TASTE DISORDER; THROAT IRRITATION; TREATMENT RESPONSE; WHEEZING;

EID: 84875970085     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.12-1533     Document Type: Article

References (31)

1. French CL, Irwin RS, Curley FJ, Krikorian CJ. Impact of chronic cough on quality of life. Arch Intern Med. 1998; 158 (15): 1657-1661.
2. Kuzniar TJ, Morgenthaler TI, Afessa B, Lim KG. Chronic cough from the patient's perspective. Mayo Clin Proc. 2007; 82 (1): 56-60.
3. Irwin RS, Baumann MH, Bolser DC, et al American College of Chest Physicians (ACCP). Diagnosis and management of cough executive summary: ACCP evidence-based clinical practice guidelines. Chest. 2006; 129 (suppl 1): 1S-23S.
4. Haque RA, Usmani OS, Barnes PJ. Chronic idiopathic cough: a discrete clinical entity? Chest. 2005; 127 (5): 1710-1713.
5. Bolser DC. Cough suppressant and pharmacologic protussive therapy: ACCP evidence-based clinical practice guidelines. Chest. 2006; 129 (1)(Suppl): 238S-249S.
6. Chung KF. Currently available cough suppressants for chronic cough. Lung. 2008; 186 (suppl 1): S82-S87.
7. Trochtenberg S. Nebulized lidocaine in the treatment of refractory cough. Chest. 1994; 105 (5): 1592-1593.
8. Udezue E. Lidocaine inhalation for cough suppression. Am J Emerg Med. 2001; 19 (3): 206-207.
9. Peleg R, Binyamin L. Practice tips. Treating persistent cough. Try a nebulized mixture of lidocaine and bupivacaine. Can Fam Physician. 2002; 48-275.
10. Almansa-Pastor A. Treating refractory cough with aerosols of mepivacaine. Chest. 1996; 110 (5): 1374-1375.
11. Lingerfelt BM, Swainey CW, Smith TJ, Coyne PJ. Nebulized lidocaine for intractable cough near the end of life. J Support Oncol. 2007; 5 (7): 301-302.
12. Whims LA, Zappasodi SJ, Morley TF. Nebulized lidocaine in the treatment of refractory tussive syncope. J Am Osteopath Assoc. 1998; 98 (3): 170-172.
13. Sherman JM. Breaking the cycle: lidocaine therapy for habit cough. J Fla Med Assoc. 1997; 84 (5): 308-309.
14. Chong CF, Chen CC, Ma HP, Wu YC, Chen YC, Wang TL. Comparison of lidocaine and bronchodilator inhalation treatments for cough suppression in patients with chronic obstructive pulmonary disease. Emerg Med J. 2005; 22 (6): 429-432.
15. Shirk MB, Donahue KR, Shirvani J. Unlabeled uses of nebulized medications. Am J Health Syst Pharm. 2006; 63 (18): 1704-1716.
16. Kirkpatrick MB, Sanders RV, Bass JB Jr. Physiologic effects and serum lidocaine concentrations after inhalation of lidocaine from a compressed gas-powered jet nebulizer. Am Rev Respir Dis. 1987; 136 (2): 447-449.
17. Rosenow EC III. Persistent cough: causes and cures. Hosp Pract (Minneap). 1996; 31 (9): 121-127.
18. Patterson JR, Blaschke TF, Hunt KK, Meffin PJ. Lidocaine blood concentrations during fiberoptic bronchoscopy. Am Rev Respir Dis. 1975; 112 (1): 53-57.
19. Efthimiou J, Higenbottam T, Holt D, Cochrane GM. Plasma concentrations of lignocaine during fibreoptic bronchoscopy. Thorax. 1982; 37 (1): 68-71.
20. Ameer B, Burlingame MB, Harman EM. Systemic absorption of topical lidocaine in elderly and young adults undergoing bronchoscopy. Pharmacotherapy. 1989; 9 (2): 74-81.
21. Watson WA, Sands MF, Barlow JC, Lener ME, Wilton JH. Lidocaine absorption and metabolism after oropharyngeal application in young and young-elderly adults. DICP. 1991; 25 (5): 463-465.
22. Mainland PA, Kong AS, Chung DC, Chan CH, Lai CK. Absorption of lidocaine during aspiration anesthesia of the airway. J Clin Anesth. 2001; 13 (6): 440-446.
23. Chinn WM, Zavala DC, Ambre J. Plasma levels of lidocaine following nebulized aerosol administration. Chest. 1977; 71(3): 346-348.
24. Langmack EL, Martin RJ, Pak J, Kraft M. Serum lidocaine concentrations in asthmatics undergoing research bronchoscopy . Chest. 2000; 117 (4): 1055-1060.
25. Decco ML, Neeno TA, Hunt LW, O'Connell EJ, Yunginger JW, Sachs MI. Nebulized lidocaine in the treatment of severe asthma in children: a pilot study. Ann Allergy Asthma Immunol. 1999; 82 (1): 29-32.
26. Hunt LW, Swedlund HA, Gleich GJ. Effect of nebulized lidocaine on severe glucocorticoid-dependent asthma. Mayo Clin Proc. 1996; 71 (4): 361-368.
27. Molassiotis A, Bryan G, Caress A, Bailey C, Smith J. Pharmacological and non-pharmacological interventions for cough in adults with respiratory and non-respiratory diseases: A systematic review of the literature. Respir Med. 2010; 104 (7): 934-944.
28. Morice AH, Menon MS, Mulrennan SA, et al. Opiate therapy in chronic cough. Am J Respir Crit Care Med. 2007; 175 (4): 312-315.
29. Ford JA. Misuse of over-the-counter cough or cold medications among adolescents: prevalence and correlates in a national sample. J Adolesc Health. 2009; 44 (5): 505-507.
30. Leinwand D. DEA warns of soft drink-cough syrup mix. USA Today. October 19, 2006. http://www.usatoday.com/news/nation/2006-10-18-lean-x.htm. Accessed March 9, 2012.
31. Gracious B, Abe N, Sundberg J. The importance of taking a history of over-the-counter medication use: a brief review and case illustration of "PRN" antihistamine dependence in a hospitalized adolescent. J Child Adolesc Psychopharmacol. 2010; 20 (6): 521-524.